Abhijeet Kumar — University of Arizona

Area of research

Pathology and Forensic Medicine · Genetics

Research interest

Research interests include Medicine, Ibrutinib, Immunotherapy, Cancer research, Rituximab, and Bruton's tyrosine kinase.

Recent publications

First Results from a Phase 1, First-in-Human Study of the Bruton's Tyrosine Kinase (BTK) Degrader Bgb-16673 in Patients (Pts) with Relapsed or Refractory (R/R) B-Cell Malignancies (BGB-16673-101)

Blood 2023cited by 64position: middledoi

Large scale multiomic analysis suggests mechanisms of resistance to immunotherapy in leiomyosarcoma.

Journal of Clinical Oncology 2021cited by 10position: middledoi

Treating Diffuse Large B Cell Lymphoma in the Very Old or Frail Patients

Current Treatment Options in Oncology 2018cited by 15position: firstdoi

Tumor microenvironment changes leading to resistance of immune checkpoint inhibitors in metastatic melanoma and strategies to overcome resistance

Pharmacological Research 2017cited by 62position: middledoi

Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent Lymphomas

Clinical Lymphoma Myeloma & Leukemia 2017cited by 15position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Pathology and Forensic Medicine · Genetics →